|Day Low/High||53.62 / 54.74|
|52 Wk Low/High||34.37 / 55.62|
TT is pointed up but could dip to fill the small upside price gap made Wednesday.
Amazingly, one group isn't just left behind, it just keeps losing money, while the other group is shrugging off this day with aplomb.
It may seem ridiculous, but you can distill the market down to these two names because they stand for palpable themes.
Go with the banks. They are cheap and we learned this week with that big move up in rates, they will too.
Earnings are coming, and I suggest waiting at this point on the ones that are up, but buying those that are flat to down.
The company designs and manufactures purpose-built, automotive-grade, all-electric vehicles, targeting the low-speed electric vehicle market.
This market is far from 'just right' as 3 sectors run higher while the DJIA lags far behind. With 3 doctors testifying on Capitol Hill on Tuesday, this session could be risk-heavy.
The direction of the market in the coming weeks will hinge in part on progress in reopening the U.S. and European economies.
Caterpillar is a prime example.
A subset of tech is expensive, as well as tech IPOs, but the majority of sectors are far from overvalued.
Upgrades Dova Pharmaceuticals upgraded to Outperform from In-line at Evercore ISI Meridian Bancorp upgraded to Overweight from Neutral at Piper Jaffray; price target raised to $20 Landstar System upgraded to Mkt Perform from Underperform at Raymo...
We see signs that tell us not only is this market not expensive, but there are whole sections that might be ridiculously cheap. The recent merger announcements are a prime example.
I think we can all agree that there will be no increase made to the Fed Funds Rate today.
Straying from these names could land you in quicksand as the 4th quarter begins.
Continue to trade Ingersoll-Rand from the long side looking for gains to the $113 area.
Argus Research details 24 stocks likely to be impacted, one way or the other, by trade wars and tariffs.
These companies have been the stars of the quarterly earning show so far.
Let's check out IR's charts and indicators.
This market clearly has no clue what to buy, with strong GDP growth but challenging trade dynamics and the Facebook and Twitter bombs last week.
This options strategy on SBUX offers potential reward with little risk.
Who, out there in the health care sector, is safe?
These stocks remain among the best places to be.
It looks like China is building again.
We ought to open our eyes to what we don't care about, to what's still made here.